@article{article, title  = {{Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2019}},

 month = {{11}},

 author = {{Petrylak DP and de Wit R and Chi KN and Drakaki A and Sternberg CN and Nishiyama H and Castellano D and Hussain SA and Fléchon A and Bamias A and Yu EY et al}},

 doi = {{10.1016/s1470-2045(19)30668-0}},

 volume = {{21}},

 journal = {{The Lancet Oncology}},

 issue = {{1}},

 pages = {{105-120}},

 note = {{Accessed on 2024/12/22}}}